Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Finerenone

A non-steroidal mineralocorticoid receptor antagonist, blocking the receptor for aldosterone. It was approved in the United States in 2021 for chronic kidney disease associated with type 2 diabetes, and later also for heart failure. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?Its discovery started from some 1,4-dihydropyridines, the same chemical family as nifedipine, found by high-throughput screening: by optimising them, chemists arrived at a dihydronaphthyridine.

FinerenoneGo to the active ingredient →
FinerenoneActive ingredientFinerenoneCat. No. P-F048-001CAS 1050477-31-0

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.